Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Syngene International Ltd

NSE: SYNGENE · BSE: 539268 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹361.90
Market cap
₹14,609 Cr
Revenue (annual)
₹3,739 Cr
Net profit (annual)
₹316.7 Cr
P/E (TTM)
66.1×Sector 47.4×
Promoter holding
52.59%-0.09% QoQ
FII holding
11.82%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:09 IST NSE
Results Update

Syngene International Results Update

Syngene International Ltd announced its Q1 FY27 financial results, reporting Rs. 736 Cr in revenue from operations and Rs. 91 Cr in operating EBITDA.

18:50 IST NSE
Results Update

Syngene International Results Update

Syngene International reported full-year FY26 revenue of ₹3,739 Crore, up 3% year-on-year. Q4 revenue grew 2% to ₹1,037 Crore. The company announced leadership changes, with Ms. Kiran Mazumdar-Shaw becoming Executive Chairperson and Mr. Siddharth Mittal appointed as CEO effective July 2026. A final dividend of ₹1.25 per share was recommended.

Value
₹3,739 Cr